...
首页> 外文期刊>Al Ameen Journal of Medical Sciences >Phenotypic detection of Metallo- and AmpC ?-lactamases producing strains of P. aeruginosa in the state of Himachal Pradesh (India)
【24h】

Phenotypic detection of Metallo- and AmpC ?-lactamases producing strains of P. aeruginosa in the state of Himachal Pradesh (India)

机译:在喜马al尔邦(印度)产铜绿假单胞菌菌株的金属和AmpCβ-内酰胺酶的表型检测

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: A prospective study was undertaken to detect metallo-β-lactamases (MBLs) and Amp C β-lactamases in Pseudomonas aeruginosa isolates recovered from patients at Indira Gandhi Medical College, Shimla (H.P). Objective: The study aimed at determining the prevalence of MBL and AmpC producing P. aeruginosa isolates. Material and Methods: A total of 180 isolates were preliminarily screened for their susceptibility to carbapenems (imipenem, meropenem, doripenem and ertapenem) and cefoxitin by in vitro antibiotic cultural sensitivity. The confirmation of MBL producing isolates was done b y combined disc test and E test whereas AmpC production was confirmed by disc antagonism test and E test. Results and Conclusion: P. aeruginosa isolates (22.22%) were MBL producers on the basis o f resistance to imipenem and meropenem while 60% were AmpC β-lactamase producers in preliminary screening test. Of the MBL producers, 50% isolates were confirmed b y E test and 45% by combined disc test. However, only 13.33% were positive by both the confirmatory tests. By disc antagonism test, 46.33% isolates were detected as AmpC producers while 6.67% were positive by E test. It is interesting to note that of the 180 isolates examined, 14 (7.78%) were both MBL and AmpC producers. Both MBL and AmpC as mechanisms of resistance were thus, observed amo ng the isolates of P. aeruginosa in the state of Himachal Pradesh. Emergence of such strains is of public health concern as such organisms pose therapeutic challenge.
机译:背景:进行了一项前瞻性研究,以检测从西姆拉(Indira Gandhi Medical College)的患者中回收的铜绿假单胞菌分离物中的金属β-内酰胺酶(MBL)和Amp Cβ-内酰胺酶。目的:该研究旨在确定产生MBL和AmpC的铜绿假单胞菌分离株的患病率。材料和方法:通过体外抗生素培养敏感性初步筛选了180种分离物对碳青霉烯类(亚胺培南,美罗培南,多利培南和厄他培南)和头孢西丁的敏感性。通过结合的圆盘试验和E试验确定产生MBL的分离株,而通过圆盘拮抗试验和E试验确定AmpC的产生。结果与结论:在初步筛选试验中,铜绿假单胞菌菌株(22.22%)是基于亚胺培南和美洛培南的抗药性而为MBL生产者,而60%为AmpCβ-内酰胺酶生产者。在MBL生产者中,通过E检验确认了50%的分离株,通过联合圆盘检验确认了45%。但是,两种验证性试验的阳性率均只有13.33%。通过圆盘拮抗试验,发现46.33%的分离株是AmpC产生者,而通过E检验的阳性率为6.67%。有趣的是,在检查的180个分离株中,有14个(7.78%)是MBL和AmpC的生产者。因此,在喜马al尔邦的铜绿假单胞菌分离物中观察到了MBL和AmpC作为耐药机制。这种菌株的出现是公共卫生关注的问题,因为这种微生物构成了治疗挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号